PSYCHOSIS TREATMENTS | ||||||
---|---|---|---|---|---|---|
Generic | Brand | Form | Indication | Adult Initial Dose | Adult Dose | Titration |
First-Generation Antipsychotics | ||||||
chlorpromazine HCl | — | tabs | Psychosis. Mania | Less acutely disturbed: 25mg three times daily Outpatient: 10mg 3–4 times daily or 25mg 2–3 times daily Severe cases: 25mg three times daily |
Inpatient: 500–1000mg/day Less acutely disturbed: 400mg/day Outpatient: 200–800mg/day |
Increase dose gradually until symptoms are controlled. Continue optimum dosage for 2wks; then gradually reduce to lowest effective maintenance dose. See full labeling. |
fluphenazine HCl | — | tabs, elixir, oral conc | Psychosis | 2.5–10mg daily in 3–4 divided doses | Maintenance: 1–5mg/day; max 40mg/day |
Reduce gradually to 1–5mg/day when symptoms are controlled |
haloperidol | — | inj | Schizophrenia | — | 2–5mg IM every 4–8hrs or up to hourly if needed; max: 20mg/day | Switch to oral form 12–24hrs after last inj |
tabs | Psychosis | Moderate symptoms: 0.5–2mg 2–3 times daily. Severe, chronic, or resistant symptoms: 3–5mg 2–3 times daily. Debilitated: 0.5–2mg 2–3 times daily. | Individualize. Max 100mg/day | — | ||
Haldol Decanoate | sust-rel inj | Schizophrenia when prolonged parenteral therapy required | 10–20 times previous daily dose of oral haloperidol; max initial dose: 100mg (if >100mg, give balance in 3–7 days) | Maintenance: 10–15 times previous daily dose of oral haloperidol; max: 450mg/month. | — | |
loxapine | — | caps | Schizophrenia | 10mg twice daily. Severe: up to 50mg/day in 2–4 divided doses | Maintenance: 20–60mg/day in 2–4 divided doses | May increase over first 7–10 days until effective response; usual range 60–100mg/day; max 250mg/day |
Adasuve | pwd for oral inh | Agitation due to schizophrenia | — | 10mg/24hrs | — | |
thioridazine HCl | — | tabs | Schizophrenia unresponsive to (preferably 2) other antipsychotics | 50–100mg three times daily | 200–800mg/day in 2–4 divided doses |
May increase gradually to max 800mg/day |
thiothixene | — | caps | Schizophrenia | Mild: 2mg three times daily; max 15mg/day. Severe: 5mg twice daily | 20–30mg/day; max 60mg/day | — |
trifluoperazine HCl | — | tabs | Psychosis | 2–5mg twice daily | 15–20mg/day | — |
Second-Generation Antipsychotics | ||||||
aripiprazole | Abilify | tabs | Schizophrenia | 10mg or 15mg once daily | 10–15mg/day; max 30mg/day |
May increase at intervals of at least 2wks |
Abilify Asimtufii | ext-rel IM inj |
Schizophrenia | 960mg IM once every 2mos (no sooner than 56 days after previous inj). Patients receiving Abilify Maintena: may administer in place of next scheduled inj. | 960mg IM once every 2mos (no sooner than 56 days after previous inj). | After first Asimtufii dose, continue with concurrent oral aripiprazole (10–20mg) or other antipsychotic for 14 consecutive days. May reduce to 720mg IM once every 2mos if adverse reactions occur. | |
Abilify Maintena | ext-rel inj |
Schizophrenia | 400mg IM once monthly (no sooner than 26 days after the previous inj) | 400mg IM once monthly (no sooner than 26 days after the previous inj) | After first Maintena dose, continue with concurrent oral aripiprazole (10mg or 20mg) or other antipsychotic for 14 consecutive days. May reduce to 300mg IM once monthly if adverse reactions occur. | |
Abilify Mycite | tabs with sensor | Schizophrenia | 10mg or 15mg once daily | 10–15mg/day; max 30mg/day | May increase at intervals of at least 2wks | |
aripiprazole lauroxil |
Aristada | ext-rel inj |
Schizophrenia | 441mg, 662mg, or 882mg IM once monthly (no sooner than 14 days after the previous inj), or 882mg IM once every 6wks, or 1064mg IM every 2mos. | 441mg, 662mg, or 882mg IM once monthly (no sooner than 14 days after the previous inj), or 882mg IM once every 6wks, or 1064mg IM every 2mos. | Concurrently with first Aristada dose, administer oral aripiprazole for 21 consecutive days. |
Aristada Initio | ext-rel inj | Schizophrenia when used for initiation (or reinitiation after a missed dose) of Aristada | 675mg IM once | — | Concurrently administer oral aripiprazole 30mg once. Administer first Aristada inj on same day as Aristada Initio or ≤10 days after. | |
asenapine | Saphris | SL tabs | Schizophrenia | Acute: 5mg twice daily; max 20mg/day | Maintenance: 5mg twice daily; max 20mg/day | May increase to 10mg twice daily after 1wk |
Secuado | transdermal system | Schizophrenia | One 3.8mg/24hrs patch once daily | 3.8mg/24hrs, 5.7mg/24hrs, or 7.6mg/24hrs patch once daily | May increase as needed after 1wk | |
brexpiprazole | Rexulti | tabs | Schizophrenia | 1mg once daily on days 1–4 | 2–4mg/day; max 4mg/day |
Increase to 2mg once daily on days 5–7, then 4mg once daily on day 8 |
cariprazine | Vraylar | caps | Schizophrenia | 1.5mg once daily | 1.5–6mg once daily; max 6mg/day |
May increase to 3mg on Day 2. May further adjust by 1.5mg or 3mg increments based on response and tolerability |
clozapine | Clozaril | tabs | Treatment-resistant schizophrenia. Reduce risk of recurrent suicidal behavior in schizophrenia or schizoaffective disorders. | 12.5mg 1–2 times daily | 300–450mg/day in divided doses | May increase by increments of 25–50mg/day to 300–450mg/day in divided doses by the end of 2wks. Then may increase once or twice weekly in increments of up to 100mg; max 900mg/day. Reduce gradually over 1–2wks if discontinuing; may discontinue abruptly if necessary (eg, severe neutropenia, myocarditis; may cause relapse or cholinergic rebound). Retitrate if stopped for ≥2 days. |
Versacloz | oral susp | |||||
iloperidone | Fanapt | tabs | Schizophrenia | 1mg twice daily on day 1, 2mg twice daily on day 2, 4mg twice daily on day 3, 6mg twice daily on day 4, 8mg twice daily on day 5, 10mg twice daily on day 6, 12mg twice daily on day 7 |
12–24mg/day | Retitrate if stopped for >3 days |
lumateperone | Caplyta | caps | Schizophrenia | — | 42mg once daily | — |
lurasidone HCl | Latuda | tabs | Schizophrenia | 40mg once daily | 40–160mg once daily; max 160mg/day |
— |
olanzapine | Zyprexa | tabs | Schizophrenia | 5–10mg once daily, increase to 10mg once daily within several days | 10–20mg/day; max 20mg/day |
May adjust by 5mg/day at intervals of 1wk |
Zyprexa Zydis | ODT | |||||
Zyprexa Intra-Muscular | inj | Agitation due to schizophrenia |
— | 2.5–10mg/dose IM; up to max 3 doses/day (2–4hrs apart) | Switch to oral form when appropriate | |
Zyprexa Relprevv | ext-rel inj | Schizophrenia | Target oral dose 10mg/day: 210mg every 2wks or 405mg every 4wks for first 8wks. Target oral dose 15mg/day: 300mg every 2wks for first 8wks. Target oral dose 20mg/day: 300mg every 2wks for first 8wks. |
Maintenance: Target oral dose 10mg/day: 150mg every 2wks or 300mg every 4wks. Target oral dose 15mg/day: 210mg every 2wks or 405mg every 4wks. Target oral dose 20mg/day: 300mg every 2wks. |
— | |
paliperidone | Invega | ext-rel tabs | Schizophrenia. Schizoaffective disorder. | 6mg once daily in AM | 3–12mg once daily; max 12mg/day |
May increase in increments of 3mg/day at intervals of >5 days (for schizophrenia) or >4 days (for schizoaffective disorder) |
Invega Hafyera | ext-rel inj |
Schizophrenia | Initiate Invega Hafyera dose based on the previous Invega Sustenna or Invega Trinza dose | 1092–1560mg once every 6mos | May adjust dose every 6mos between 1092mg to 1560mg based on response and tolerability | |
Invega Sustenna | ext-rel inj |
Schizophrenia. Schizoaffective disorder. | 234mg IM on day 1, then 156mg IM one week later | Maintenance: Schizophrenia: 117mg IM (39–234mg) once monthy; max 234mg/month Schizoaffective: 78–234mg IM once monthly; max 234mg/month |
— | |
Invega Trinza | ext-rel inj | Schizophrenia | Give when next Invega Sustenna dose is scheduled using 3.5-fold higher dose equivalent (see full labeling) | Give once every 3mos | May adjust dose every 3mos in increments of 273–819mg based on tolerability and/or efficacy | |
pimavanserin | Nuplazid | tabs, caps | Parkinson disease psychosis | — | 34mg once daily | — |
quetiapine fumarate | Seroquel | tabs | Schizophrenia | 25mg twice daily on day 1; increase by 25–50mg 2–3 times daily on days 2 and 3; target 300–400mg/day in 2–3 divided doses by day 4 | 400–800mg/day in divided doses; max 800mg/day | May adjust at 2-day intervals by 25–50mg twice daily up to max 750mg/day |
Seroquel XR | ext-rel tabs | Schizophrenia | 300mg once daily in the PM | 400–800mg/day; max 800mg/day |
May increase at 1-day intervals in increments of up to 300mg/day | |
risperidone | Perseris | ext-rel inj | Schizophrenia | 90mg or 120mg SC once monthly | 90–120mg/month; max 1 dose/month | — |
— | ODT | Schizophrenia | 2mg/day in 1–2 doses | 4–16mg/day; max 16mg/day |
May increase by 1–2mg/day at intervals of at least 24hrs to target dose 4–8mg/day |
|
Risperdal | tabs, soln | |||||
Risperdal Consta | long- acting inj |
Schizophrenia | Give with oral risperidone (or other antipsychotic) for 3wks, then stop oral form | 25mg IM every 2wks; max 50mg every 2wks |
May adjust dose every 4wks | |
Uzedy | ext-rel SC inj | Schizophrenia | 50mg, 75mg, 100mg, or 125mg SC once monthly, or 100mg, 150mg, 200mg, or 250mg SC once every 2mos, the day after last dose of oral risperidone. | 50mg, 75mg, 100mg, or 125mg SC once monthly, or 100mg, 150mg, 200mg, or 250mg SC once every 2mos. | May switch between once monthly and once every 2mos dosing by administering the first dose of the new dosing regimen on the next scheduled inj. | |
ziprasidone HCl | Geodon | caps | Schizophrenia | 20mg twice daily | 20–80mg twice daily; max 80mg twice daily | May increase at intervals of at least 2 days |
ziprasidone mesylate | Geodon for Injection | inj | Rapid control of acute agitation | 10–20mg IM as needed | Max 40mg/day (10mg every 2hrs; or 20mg IM every 4hrs); treat for max 3 days | Switch to oral form as soon as possible |
Others | ||||||
dexmedetomidine | Igalmi | SL film | Agitation due to schizophrenia | — | Mild to moderate: initially 120mcg; may give 2nd/3rd doses of 60mcg for a max total daily dose of 240mcg. Severe: initially 180mcg; may give 2nd/3rd doses of 90mcg for a max total daily dose of 360mcg |
— |
olanzapine, samidorphan | Lybalvi | tabs | Schizophrenia | 5mg/10mg or 10mg/10mg once daily | 5mg/10mg–20mg/10mg once daily | May adjust at weekly intervals of 5mg as tolerated; max: 20mg/10mg once daily |
NOTES | ||||||
Key: ext-rel = extended-release; immediate-rel = immediate-release; ODT = orally-disintegrating tablets; SL = sublingual; sust-rel = sustained-release (Rev. 8/2023) |
Please login or register first to view this content.